Alignment Healthcare (ALHC) CFO sells 11,100 shares to cover tax obligations

Rhea-AI Filing Summary

Alignment Healthcare, Inc. Chief Financial Officer James M. Head reported a mandatory share sale tied to equity compensation. On April 7, 2026, he disposed of 11,100 shares of common stock at $21.08 per share to cover tax withholding obligations from vesting restricted stock units. A footnote explains this was not a discretionary trade. After this transaction, he directly holds 173,495 shares of Alignment Healthcare common stock.

Insider Trade Summary

Net Seller: 11,100 shares ($233,988)

Net Sell 1 txn

Insider Head James M

Role Chief Financial Officer

Sold 11,100 shs ($234K)

Type	Security	Shares	Price	Value
Sale	Common Stock	11,100	$21.08	$234K

Holdings After Transaction: Common Stock — 173,495 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares disposed: 11,100 shares Sale price: $21.08 per share Shares held after transaction: 173,495 shares

3 metrics

Shares disposed 11,100 shares Common stock sold on April 7, 2026

Sale price $21.08 per share Price for tax-withholding-related sale

Shares held after transaction 173,495 shares Direct holdings after reported disposition

Key Terms

restricted stock units, tax withholding obligations, non-derivative, open-market sale

4 terms

restricted stock units financial

"in connection with the vesting of restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"shares required to be sold ... to cover tax withholding obligations"

non-derivative financial

""transaction_type": "non-derivative""

open-market sale financial

""transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Head James M

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY ROAD

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/07/2026		S		11,100(1)	D	$21.08	173,495	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

Remarks:

	/s/ Christopher Joyce, as Attorney-in-Fact, for James M. Head	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ALHC CFO James M. Head report?

James M. Head reported a disposition of 11,100 shares of Alignment Healthcare common stock. The shares were sold to satisfy tax withholding obligations arising from restricted stock unit vesting, rather than as a discretionary open-market trade or portfolio decision.

At what price were the ALHC shares related to the CFO’s Form 4 sold?

The 11,100 Alignment Healthcare shares were sold at $21.08 per share. This price reflects the execution level used to cover statutory tax withholding associated with newly vested restricted stock units, as described in the filing’s footnote.

How many ALHC shares does the CFO hold after this Form 4 transaction?

Following the tax-related sale, James M. Head directly holds 173,495 shares of Alignment Healthcare common stock. This post-transaction balance reflects his remaining equity position after disposing of 11,100 shares to satisfy withholding obligations.

Was the ALHC CFO’s reported sale a discretionary trade?

No, the sale was not discretionary. A footnote states the 11,100 shares represented the amount required to be sold to cover tax withholding obligations from restricted stock unit vesting, indicating a mechanical transaction rather than an active trading decision.

What type of security is involved in the ALHC CFO Form 4 filing?

The Form 4 involves Alignment Healthcare common stock associated with restricted stock units. The reported sale of 11,100 shares at $21.08 per share was executed solely to cover tax withholding triggered when those restricted stock units vested.